MaxCyte grants 220,000 stock options, 110,000 RSUs to new corporate development chief Kapileshwar

PUBT · 2d ago
MaxCyte grants 220,000 stock options, 110,000 RSUs to new corporate development chief Kapileshwar
  • MaxCyte granted inducement equity awards to new Chief Corporate Development Officer Sidharth Kapileshwar under its 2026 Inducement Plan.
  • Package totals 220,000 stock options, exercise price $1.29, 10-year term; vesting spans four years with monthly vesting after year one.
  • Award also includes 110,000 service-based RSUs; 25% vests on Aug. 31, 2027, remainder in three equal annual installments.
  • Grant date was Aug. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MaxCyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609111630PRIMZONEFULLFEED9825442) on September 11, 2026, and is solely responsible for the information contained therein.